Main Menu
Search
Close this search box.
Donate
Sign Up

Metabolic Differentiation of ME/CFS Comorbidities

Study AIM

To investigate the metabolite signatures of ME/CFS patient stool, urine and blood samples and the impact that co-morbidities (IBS and Fibromyalgia) have on these signatures.

LEAD INVESTIGATORS
  • Amber Jaa-Kwee
  • Christopher Armstrong, PhD
Updates and Potential
  • All samples have been collected and assayed.
  • Currently analyzing data from this study.
  • Early analysis indicate that comorbidities do impact profiles and agree with previous metabolic studies on comorbidities.
  • Have expanded study to target Kynurenine pathway, NAD metabolites and cytokines in the blood.
STUDY HYPOTHESIS AND DESCRIPTION

ME/CFS patients often suffer from multiple comorbidities. When observing a cohort of ME/CFS patients we often neglect to consider the impact that co-morbidities are having on the biological signatures produced that might be distinct from ME/CFS alone. In this study we look at ME/CFS patients with and without IBS and Fibromyalgia to determine the impact of these comorbidities.

We expect their impact will highlight the importance of matching for co-morbidities when conducting case-control studies.

OBJECTIVES

  1. Produce  a comprehensive metabolic profile of plasma, urine and stool samples to contrast ME/CFS patients and controls.
  2. Establish the potential relationships between gut bacteria, host metabolism and ME/CFS.
  3. Compare 22 ME/CFS with Fibromyalgia and 22 ME/CFS without to determine impact on metabolic signatures.
  4. Compare 22 ME/CFS with IBS and 22 ME/CFS without to determine impact on metabolic signatures.
  5. Cluster ME/CFS patients to assess biases of comorbidities.
Other links you might be interested in:
OMF Milestones
University of Montreal Collaborative Research Center
Facebook Twitter Youtube Instagram Linkedin

OMF is a non-profit 501(c)(3) organization
(EIN# 26-4712664). All donations are tax-deductible to the extent allowed by law.

Open Medicine Foundation®
29302 Laro Drive,  Agoura Hills, CA 91301 USA
Phone: 650-242-8669
info@omf.ngo

Contact Us

PRIVACY  |  COOKIE   |   CONSENT   |  MEDICAL & OTHER DISCLAIMERS

Copyright © 2023 Open Medicine Foundation. All Rights Reserved.

Consent management

Consent Preferences

Data Subject Access Request (DSAR) Form 

Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation®

What are the advantages of giving from your Donor Advised Fund (DAF)?

  • Your gifts to your donor advised fund entitle you to an immediate income tax deduction at the time of contribution.
  • You avoid capital gains tax on appreciated assets you place in your donor advised fund.
  • Your fund’s investment gains accumulate tax free.
  • Funds are distributed to Open Medicine Foundation in your name and immediately put to use to support our worldwide research efforts.


How do I make a donation through my DAF?

Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.

Still can’t find your fund? 

  • Request a grant distribution through your Donor Advised Fund sponsor
  • Be sure to use OMF’s EIN #26-4712664
  • You can also designate OMF as a beneficiary for your Donor Advised Fund
  • Questions? Give us a call at 650-242-8669 
 
Donate